- Home
- BTAI vs FUSE Comparison
BTAI vs FUSE Comparison
Compare BTAI & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | FUSE |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 48.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTAI | FUSE |
|---|---|---|
| Price | $1.60 | $1.61 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 463.9K | 112.0K |
| Earning Date | 11-12-2025 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $752,000.00 | ★ $8,847,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $441.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.65 |
| 52 Week Low | $1.17 | $1.45 |
| 52 Week High | $9.26 | $25.00 |
Technical Indicators
Market Signals| Indicator | BTAI | FUSE |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | N/A |
| Support Level | $1.50 | N/A |
| Resistance Level | $1.89 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 13.77 | 0.00 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About FUSE Fusemachines Inc.
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.